HB 4423 requires the Oklahoma Health Care Authority to verify the immigration status of all Medicaid applicants using the federal SAVE system (or its successor) before approving benefits. It specifically mandates that the Authority notify U.S. Immigration and Customs Enforcement (ICE) if an applicant's status cannot be verified as lawful. This applies to all applicants, including adults applying for child-only Medicaid benefits on behalf of a child. The bill takes effect October 1, 2026, and does not change Medicaid eligibility criteria but adds a verification step for immigration status.
SB 1425 repeals three existing Oklahoma statutes related to health care workforce programs: 70 O.S. 2021 §2640 (Oklahoma Health Care Workers and Educators Assistance Program) and 74 O.S. 2021 §§3200.1-3200.2 (Health Care Workforce Resources Act). This bill eliminates the legal framework for these specific programs, which previously provided assistance to health care workers and educators. The repeal takes effect on November 1, 2026, and directly affects the administrative structure and operations of those programs. No new provisions or funding are created; the bill solely removes the existing laws.
HB 3767 adds specific synthetic drugs and substances to Oklahoma's Schedule I and IV of controlled dangerous substances under state law. It directly affects anyone possessing, distributing, or using the newly listed compounds, including various fentanyl analogs (like para-fluorofentanyl), synthetic hallucinogens (like psilocybin and salvia), and other novel psychoactive substances. The bill amends Oklahoma's Controlled Dangerous Substances Act by expanding the official lists in Schedule I (substances with no medical use and high abuse potential) and Schedule IV (substances with accepted medical use but potential for abuse). This creates new legal prohibitions for these substances without requiring additional medical or legal exceptions.
HB 4294 requires health insurers in Oklahoma to provide equal coverage for epilepsy as for other conditions, prohibiting termination or non-renewal of policies solely due to an epilepsy diagnosis. It mandates coverage for seizure prevention devices, surgeries, or medical procedures prescribed by an epilepsy specialist when medically necessary to reduce SUDEP (sudden unexpected death in epilepsy) risk. The law applies to all individual and group health insurance plans covering medical/surgical benefits and takes effect November 1, 2026. This directly affects epilepsy patients and insurers offering such coverage in Oklahoma.
SB 1849 modifies Oklahoma's continuing education requirements for podiatrists renewing their licenses. It mandates 60 hours of continuing education every two years, including at least 2 hours on pain management, opioid use, or addiction (unless the practitioner lacks a federal DEA registration). The bill broadens acceptable continuing education to include medical marijuana training approved by the Board and allows out-of-state practitioners to substitute hours from where they practice. Fully retired podiatrists are exempt but must complete accrued requirements if they resume practice. The changes take effect November 1, 2026.
SB 1567 modifies Oklahoma's rules for Advanced Practice Registered Nurses (APRNs) by allowing supervising physicians to charge reasonable fees for oversight services, requiring these fees to be disclosed in written agreements and based on fair market value. The bill prohibits the Oklahoma Board of Nursing from imposing fees for maintaining supervision agreements or related administrative tasks. It also mandates that supervision agreements include specific details like fee structures, scope of practice, emergency plans, and alternate physician designations. This directly affects APRNs who rely on physician supervision and supervising physicians, streamlining oversight requirements while ensuring transparency in fee arrangements.
HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
